#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Central nervous system neoplasm Cytomegalovirus infection Alpha-1 antitrypsin deficiency Rhabdomyosarcoma recurrent Squamous cell carcinoma of the hypopharynx Follicle centre lymphoma follicular grade I, II – III Osteopetrosis Hairy cell leukaemia Pulmonary sarcoidosis Fibrous dysplasia of bone Small cell lung cancer Congenital absence of bile ducts Juvenile idiopathic arthritis Cutaneous T-cell lymphoma refractory Splenic marginal zone lymphoma More trials…

    Learn about Rare Diseases

    Rhabdoid tumour – Life with Disease Mast cell activation syndrome – Diagnostics Glycogen storage disease type II – Trials in Disease Cystic fibrosis – Diagnostics Myelodysplastic syndrome – Trials in Disease Crigler-Najjar syndrome – Basic Information Mantle cell lymphoma refractory – Treatment Loeys-Dietz syndrome Von Willebrand’s disease – Treatment Retinoblastoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Aceclofenac Tetrahydrouridine Methylprednisolone Arachis Hypogaea Flour BMS-986365 Ceritinib Cemdisiran Human Coagulation Factor Ii Folic Acid, Anhydrous Octreotide Hydroxyzine Hydrochloride Cetrelimab Omx-0407 HYALURONIDASE Meropenem Trihydrate Ferric Derisomaltose Nvl-655 Garadacimab Indapamide Calcipotriol More therapies…

    Learn about Your Condition

    Elderly Traumatic pain Oral herpes Foetal growth restriction Brain abscess Diabetes insipidus Deep vein thrombosis Medulloblastoma recurrent Cluster headache Lung adenocarcinoma stage IV Intervertebral disc protrusion Addison's disease Hodgkin's disease refractory Generalised anxiety disorder Ovarian granulosa cell tumour More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Circulatory and Respiratory Physiological Phenomena

  • Study on the Effects of Ringer’s Acetate Solution in Healthy Volunteers with Experimental Low Blood Volume

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Magnesium Chloride Hexahydrate
    • Sodium Acetate Trihydrate
    • Calcium Chloride Dihydrate
    Norway

  • Study of sildenafil to improve walking distance in patients with peripheral arterial disease and intermittent claudication

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Peripheral arterial occlusive disease
    Investigated Drugs:
    • Microcrystalline Cellulose
    • Sildenafil Citrate
    France

  • Study on Osimertinib for Patients with Stage III Unresectable Non-Small Cell Lung Cancer After Chemoradiation Therapy

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Osimertinib
    • Placebo
    Spain

  • Study of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Hormone-dependent prostate cancer
    Investigated Drugs:
    • Capivasertib
    • Abiraterone Acetate
    Belgium Bulgaria Czechia France Germany The Netherlands +3

  • Study on Brentuximab Vedotin, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Brentuximab Vedotin
    • Lenalidomide
    • Rituximab
    Belgium Czechia Denmark France Italy Poland +1

  • Study on the Effects of Cold and Room Temperature Ringer’s Lactate Solution on Blood Flow and Clotting in Healthy Adults

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • SODIUM LACTATE (AS 50% SOLUTION)
    • Calcium Chloride Dihydrate
    • Potassium Chloride
    Denmark
Previous Page
1 2 3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!